Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Change Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Change Healthcare's CEO'su Neil de Crescenzo, Jan2013 tarihinde atandı, in görev süresi 9.75 yıldır. in toplam yıllık tazminatı $ 9.33M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9.5% maaş ve 90.5% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.18% ine doğrudan sahiptir ve bu hisseler € 16.58M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.5 yıl ve 5.8 yıldır.

Anahtar bilgiler

Neil de Crescenzo

İcra Kurulu Başkanı

US$9.3m

Toplam tazminat

CEO maaş yüzdesi	9.5%
CEO görev süresi	9.8yrs
CEO sahipliği	0.2%
Yönetim ortalama görev süresi	2.5yrs
Yönetim Kurulu ortalama görev süresi	5.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Neil de Crescenzo'un ücretlendirmesi Change Healthcare'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2022	n/a	n/a	-US$77m
Mar 31 2022	US$9m	US$882k	-US$57m
Dec 31 2021	n/a	n/a	-US$78m
Sep 30 2021	n/a	n/a	-US$51m
Jun 30 2021	n/a	n/a	-US$57m
Mar 31 2021	US$10m	US$850k	-US$112m
Dec 31 2020	n/a	n/a	-US$966m
Sep 30 2020	n/a	n/a	-US$917m
Jun 30 2020	n/a	n/a	-US$969m
Mar 31 2020	US$10m	US$850k	-US$948m
Dec 31 2019	n/a	n/a	-US$84m
Sep 30 2019	n/a	n/a	-US$147m
Jun 30 2019	n/a	n/a	-US$72m
Mar 31 2019	US$2m	US$750k	-US$52m
Dec 31 2018	n/a	n/a	-US$70m
Sep 30 2018	n/a	n/a	US$71m
Jun 30 2018	n/a	n/a	US$67m
Mar 31 2018	US$8m	US$743k	US$61m

Tazminat ve Piyasa: Neil 'nin toplam tazminatı ($USD 9.33M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 3.18M ).

Tazminat ve Kazançlar: Neil 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Neil de Crescenzo (61 yo)

9.8yrs

Görev süresi

US$9,329,762

Tazminat

Mr. Neil E. de Crescenzo, IV serves as President and Chief Executive Officer at Change Healthcare, Inc. since 2013 and has been its Director since 2017. He has been the Chief Executive Officer and Presiden...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Neil de Crescenzo	President	9.8yrs	US$9.33m	0.18% € 16.6m
Fredrik Eliasson	Executive VP & CFO	4.6yrs	US$5.00m	0.073% € 6.7m
Steven Martin	Executive Vice President of Enterprise Technology	2.5yrs	US$2.73m	0.027% € 2.5m
Kriten Joshi	Executive VP and President of Network Solutions	no data	US$3.14m	0.066% € 6.0m
Roderick O'Reilly	Senior Advisor	less than a year	US$2.52m	0.011% € 1.0m
August Calhoun	Executive VP and President of Sales & Operations	no data	US$2.65m	0.021% € 1.9m
David Elliott	Senior Director	no data	Veri yok	Veri yok
Loretta Cecil	Executive VP & General Counsel	no data	Veri yok	0.016% € 1.4m
Monica McCullough	Chief Compliance & Ethics Officer	2.1yrs	Veri yok	Veri yok
Katherine Wojtecki	Vice President of External Communications	2.3yrs	Veri yok	Veri yok
W. McEnery	Executive VP of Corporate Affairs & Chief Marketing Officer	no data	Veri yok	0.035% € 3.2m
Ryan Miller	Senior Vice President of Corporate Development	2.9yrs	Veri yok	Veri yok

2.5yrs

Ortalama Görev Süresi

55.5yo

Ortalama Yaş

Deneyimli Yönetim: 1CB 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.5 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Neil de Crescenzo	President	5.8yrs	US$9.33m	0.18% € 16.6m
Neil Simpkins	Independent Director	5.8yrs	Veri yok	Veri yok
Philip Pead	Independent Director	5.8yrs	US$315.20k	0.029% € 2.7m
Robert Zollars	Independent Director	5.8yrs	US$300.20k	0.010% € 923.8k
Howard Lance	Independent Chairman	5.8yrs	US$465.20k	0.067% € 6.1m
Phillip Roe	Independent Director	5.8yrs	US$315.20k	0.010% € 923.8k
Bansi Nagji	Independent Director	5.8yrs	US$285.20k	0.0096% € 883.5k
Diana McKenzie	Independent Director	3.2yrs	US$285.20k	0.010% € 923.8k
Nicholas Kuhar	Independent Director	3.3yrs	Veri yok	Veri yok
Nella Domenici	Independent Director	2.4yrs	US$285.20k	0.0066% € 604.6k

5.8yrs

Ortalama Görev Süresi

61yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 1CB 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.8 yıldır).

Change Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

IKS Health, Appoints Laura Anderson as Chief Product Officer

Insufficient new directors

Change Healthcare Inc. Announces Management Changes

Change Healthcare Inc., Annual General Meeting, Mar 29, 2022

Insider recently sold €83k worth of stock

Insider recently sold €165k worth of stock

Recent updates

IKS Health, Appoints Laura Anderson as Chief Product Officer

Gibbs Law Group Files a Class Action Lawsuit Against Change Healthcare Inc

Change Healthcare Expands Functionality and Drives Industry Transition to Cloud-Based Imaging and Storage

Change Healthcare Inc.(NasdaqGS:CHNG) dropped from S&P TMI Index

Optum, Inc. completed the acquisition of Change Healthcare Inc. (NasdaqGS:CHNG) from Blackstone Capital Partners VI, L.P., other funds managed by The Blackstone Group Inc. (NYSE:BX), Camber Capital Management LLC and others in a merger of equals transaction.

Change Healthcare Inc. Announces Special Cash Dividend, Payable on or About the First Business Day Following the Closing of the Merger

Forecast breakeven date pushed back to 2025

Insufficient new directors

Forecast breakeven date moved forward to 2023

First quarter 2023 earnings released: US$0.071 loss per share (vs US$0.011 loss in 1Q 2022)

Change Healthcare Inc. to Report Q1, 2023 Results on Aug 03, 2022

Change Healthcare in Collaboration with Luma Health Launches Patient Engagement

Forecast breakeven date pushed back to 2024

Full year 2022 earnings released: US$0.18 loss per share (vs US$0.35 loss in FY 2021)

Change Healthcare Inc. to Report Q4, 2022 Results on May 25, 2022

Funds managed by TPG Capital, L.P. entered into an agreement to acquire the claims editing business of Change Healthcare Inc. (NasdaqGS:CHNG) for $2.2 billion.

Change Healthcare Launches InterQual 2022, Delivering the Latest Evidence-Based Criteria and Technology to Optimize Clinical Decision Support

Change Healthcare Inc. Announces Management Changes

Change Healthcare Inc. Pays Special Cash Dividend

Change Healthcare Inc., Annual General Meeting, Mar 29, 2022

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Change Healthcare Reportedly Considering Selling Some Assets Including ClaimsXten Business

Insider recently sold €83k worth of stock

Insider recently sold €165k worth of stock

Second quarter 2022 earnings released: US$0.12 loss per share (vs US$0.13 loss in 2Q 2021)

Forecast breakeven pushed back to 2023

Change Healthcare Releases End-To-End, Cloud-Native Solution for Medical Imaging

First quarter 2022 earnings released: US$0.012 loss per share (vs US$0.18 loss in 1Q 2021)

Change Healthcare Inc.(NasdaqGS:CHNG) dropped from Russell 2500 Growth Index

Change Healthcare Enhances Developers’ Ability to Scale API Use and Comply with Pending CMS Interoperability Rule

Change Healthcare Launches No-Fee, Privacy-Protecting, Portable Vaccination Record

Change Healthcare in Collaboration with AWS Announces New Data Science as A Service Offering to Drive Improved Outcomes and Healthcare Economics for Vulnerable Health Communities

New 90-day high: €19.80

Change Healthcare Inc. to Report Q3, 2021 Results on Feb 03, 2021

New 90-day high: €19.50

New 90-day high: €15.40

Change Healthcare Continues to Lead the Industry in Taking Enterprise Imaging to the Cloud

New 90-day high: €14.50

New 90-day high: €13.14

Change Healthcare Announces A New Solution That Makes It Easier for Consumers to Get COVID-19 Testing in Their Local Pharmacies

Change Healthcare Inc. (NasdaqGS:CHNG) acquired Nucleus.io from NucleusHealth, LLC.

Change Healthcare Inc. (NasdaqGS:CHNG) acquired PROMETHEUS Analytics from Altarum Institute.

Change Healthcare Inc. Not Provides Guidance for the Year 2021

Change Healthcare Inc. (NasdaqGS:CHNG) acquired eRx Network, LLC for approximately $210 million.

Change Healthcare Inc. to Report Q1, 2021 Results on Aug 05, 2020

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş